Klaus Meier

Papers

Total Citations

H-Index

About

Klaus Meier is a leading voice in the advancement of oncology pharmacy across Europe. His research centers on the evolving role of pharmacists in cancer care, professional standards, and the future of the field. As a key figure in the European Society of Oncology Pharmacy (ESOP), Meier’s most notable contribution is his comprehensive survey work, including the highly cited 2022 study, “Beliefs and perspectives on the future of oncology pharmacy—collated results of member surveys of the European Society of Oncology Pharmacy.” This landmark paper, with 3 citations, mapped the needs, interests, and predictions of nearly 4,000 members across 66 countries, providing a critical roadmap for the profession’s development. By systematically capturing the collective wisdom of oncology pharmacists, Meier has helped shape strategic priorities, from specialized training to patient safety innovations. His work underscores the growing impact of pharmacy in multidisciplinary cancer teams, making him an influential advocate for elevating the profession’s role in improving patient outcomes.